Sensory Block Onset: Epidural vs Dural Puncture Epidural in Cesarean Section

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
AgeNot listed
SponsorGadjah Mada University

About this trial

The goal of this clinical trial is to compare the onset of sensory block between epidural anesthesia and dural puncture epidural (DPE) in patients undergoing elective cesarean delivery. The study also aims to evaluate hemodynamic stability and procedure-related side effects associated with both techniques.

The main questions it aims to answer are:

1. What is the difference in the onset of sensory block between epidural anesthesia and dural puncture epidural (DPE) in patients undergoing cesarean section? 2. Are there differences in hemodynamic stability between epidural anesthesia and DPE during surgery? 3. What procedure-related side effects occur with each anesthetic technique?

Researchers will compare epidural anesthesia with dural puncture epidural (DPE) to determine which technique achieves a faster and more effective sensory block while maintaining maternal hemodynamic stability.

Participants will:

1. Be randomly assigned to receive either epidural anesthesia or DPE anesthesia 2. Undergo elective cesarean delivery under regional anesthesia 3. Have sensory block onset, hemodynamic parameters, and adverse events monitored and recorded intraoperatively

Eligibility criteria

Qualifiers

Pregnant women scheduled to undergo cesarean delivery

American Society of Anesthesiologists (ASA) physical status II-III

Willing to participate in the study by providing written informed consent

Disqualifiers

Patients with absolute contraindications to neuraxial anesthesia

Patients with known allergy or history of allergy to medications used in the study

Patients with psychiatric disorders or who are uncooperative

Patients with accidental dural puncture

Trial design

Treatments tested in this trial

  • Dural Puncture Epidural (DPE) Anesthesia
  • epidural anesthesia

Treatment groups

72 Participants
are divided into 2 treatment groups

Sponsors and collaborators